Fuad El-Hibri Blog

About Fuad El-Hibri on Atlanta Business Chronicle

Fuad El-Hibri is the President, Chief Executive Officer and Chairman of the Board of Directors of Emergent Biosolutions, a Maryland-based biotechnology company focused on the development, manufacture and commercialization of immunobiotics. Emergent is the sole manufacturer of and FDA-licensed anthrax vaccine, BioThrax. Mr. El-Hibri is a member of the Board of Trustees of American University and of the International Biomedical Research Alliance.

Professional Biography

Organization	Position	Status
Emergent BioSolutions Inc.	Chief Executive Officer	Current
The National Health Museum, Inc	President, Chief Executive Officer and Chairman of the Board of Directors of Emergent Biosolutions	Current
Emergent BioSolutions Inc.	President	Current
Emergent BioSolutions Inc.	Chairman of the Board of Directors	Current
American University	Board of Directors	Current

Recent News About Fuad El-Hibri

• Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine Adsorbed) to 4 Years [Business Wire]

• Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine… [Forbes.com]

• UPDATE 1-Emergent gets anthrax vaccine expiry date extension [Reuters]

• Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine Adsorbed) to 4 Years [Reuters]

BioWatch: Emergent gets boost from FDA [Gazette.net]